Comparison of medium-term outcomes obtained with drug-eluting stents and coronary artery bypass grafts in an unselected population of diabetic patients with multivessel coronary disease. Propensity score analysis;Comparación de los resultados clínicos a medio plazo de los stents farmacoactivos frente a la cirugía de revascularización coronaria en una población no seleccionada de pacientes diabéticos con afección multivaso. Análisis mediante propensity score

Revista Espanola de Cardiologia

Volumn 62, Issue 5, 2009, Pages 491-500

  Domínguez Franco, Antonio J ^a,b,c   Jiménez Navarro, Manuel F ^a   Hernández García, José M ^a   Alonso Briales, Juan H ^a   Linde Estrella, Antonio L ^a   Pérez González, Olga ^b   Leruite Martín, Inés ^a   Olalla Mercadé, Eduardo ^a   De Teresa Galván, Eduardo ^a  

^a Hospital Clinico   (Spain)

^b Hospital University Carlos Haya de Málaga   (Spain)

^c Campus de Teatinos ^*  (Spain)

Author keywords

Cirug a de revascularizaci n coronaria; Coronary artery bypass grafting; Diabetes mellitus; Drug eluting stents; Propensity score; Stents liberadores de f rmaco

Indexed keywords

PACLITAXEL; RAPAMYCIN; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RESTENOSIS; STROKE; COHORT ANALYSIS; DIABETIC ANGIOPATHY; GRAFT OCCLUSION; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 68049137535     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71029-2     Document Type: Article

References (35)

1. P. Garg, S.L. Normand, T.S. Silbaugh, R.E. Wolf, K. Zelevinsky, and A. Lovett Drug-eluting or bare-metal stenting in patients with diabetes mellitus. Results from the Massachusetts Data Analysis Center Registry Circulation 118 2008 2277 2285
2. A. Abizaid, R. Kornowski, G.S. Mintz, M.K. Hong, A.S. Abizaid, and R. Mehran The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589
3. A. Abizaid, M.A. Costa, D. Blanchard, M. Albertal, H. Eltchaninoff, G. Guagliuni Ravel Investigators Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL trial Eur Heart J 25 2004 107 112
4. I. Moussa, M.B. Leon, D.S. Baim, W.W. O'Neill, J.J. Popma, and M. Buchbinder Impact of sirolimus eluting-stents on outcome in diabetic patients Circulation 109 2004 2273 2278
5. J.B. Hermiller, A. Raizner, L. Cannon, P.A. Gurbel, M.A. Kutcher, S.C. Wong TAXUS-IV Investigators Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial J Am Coll Cardiol 45 2005 1172 1179
6. M. Sabaté, P. Jiménez-Quevedo, D.J. Angiolillo, J.A. Gómez Hospital, F. Alfonso, R. Hernández Antolín DIABETES Investigators Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients. The Diabetes and Sirolimus-eluting stent (DIABETES) trial Circulation 112 2005 2175 2183
7. C. Macaya, H.M. García García, A. Colombo, M.C. Morice, V. Legrand, and K.H. Kuck One-year results of coronary revascularization in diabetic patients with multivessel coronary disease. Sirolimus stent vs. coronary artery by-pass surgery and bare metal stent: insights from ARTS-II and ARTS-I Eurointervention 2 2006 69 76
8. S.C. Smith Jr, J. Allen, S.N. Blair, S.N. Blair, R.O. Bonow, L.M. Brass AHA/ACC: National Heart, Lung and Blood Institute AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372 (Pubitemid 43947981)
9. J.L. Anderson, C.A. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: Executive summary Circulation 116 2007 803 877
10. G. Sianos, M. Morel, A.P. Kappetein, M.C. Morice, A. Colombo, and K. Dawkins The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease Eurointervention 2 2005 219 227
11. S.A. Nashef, F. Roques, P. Michel, E. Gauducheau, S. Lemeshow, and R. Salamon European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 19 1999 9 13
12. R.B. D'Agostino Tutorial in biostatistics - propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
13. R.B. D'Agostino Jr Propensity scores in cardiovascular research Circulation 115 2007 2340 2343
14. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. Van Es Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. The BARI investigators Seven years outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetes status Circulation 35 2000 1122 1129
16. S.B.I. King, A.S. Rosinski, R.A. Guyton, N.J. Lembo, and W.S. Weintraub Eight year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol 35 2000 1116 1121
17. P.W. Serruys, F. Unger, E. Sousa, A. Jatene, H.J. Bonnier, J.P. Schonberger Arterial Revascularization Therapies Study Group Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124
18. SoS Investigators Coronary Artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary disease (the Stent or Surgery trial) Lancet 360 2002 965 970
19. S.P. Sedlis, D.A. Morrison, J.D. Lorin, R. Esposito, G. Sethi, J. Sacks Investigators of AWESOME Percutaneous coronary intervention versus coronary artery bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry J Am Coll Cardiol 40 2002 1555 1566 (Pubitemid 35253632)
20. S.P. Marso, M. Lincoff, S. Ellis, D.L. Bhatt, J.F. Tanguay, and N.S. Kleiman Optimizing the percutaneous interventional outcomes for diabetic patients with diabetes mellitus. Results of the EPISTENT Diabetic Substudy Circulation 100 1999 2477 2484
21. K. Anastasiadis, and G. Moschos Diabetes mellitus and coronary revascularization procedures Int J Cardiol 119 2007 10 14
22. M. Hordijk-Trion, M. Lezen, W. Wijns, P. De Jaegere, M.L. Simoons, O.P. Scholte EHS-CR Investigators Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization Eur Heart J 27 2006 671 678
23. F. Feit, M.M. Brooks, G. Sopko, N.M. Keller, A. Rosen, and R. Krone Long-term clinical outcome in the bypass angioplasty revascularization investigation registry: Comparison with the randomized trial Circulation 101 2000 2795 2802 (Pubitemid 30396009)
24. C. Brigouri, G. Condorelli, F. Airoldi, A. Focaccio, D. D'Andrea, and M. Cannavale Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus Am J Cardiol 99 2007 779 784
25. V.H. Thourani, W.S. Weintraub, B. Stein, S.S. Gebhart, J.M. Craver, and E.L. Jones Influence of diabetes mellitus on early and late outcome after coronary bypass grafting Ann Thorac Surg 67 1999 1045 1052
26. M.J. Magee, T.M. Dewey, T. Acuff, J.R. Edgerton, J.F. Hebeler, and S.L. Prince Influence of diabetes mellitus on mortality and morbidity: off-pump coronary artery by-pass grafting versus coronary by-pass grafting with cardiopulmonary by-pass Ann Thorac Surg 72 2001 776 780
27. F.W. Selke, M. DiMaio, L.R. Caplan, T.B. Ferfuson, T.J. Gardner, L.F. Hiratzka American Heart Association Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research Circulation 111 2005 2858 2864
28. The BARI investigators Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Circulation 96 1997 1761 1769
29. A.T. Ong, and P.W. Serruys Complete revascularization. Coronary artery bypass graft surgery versus percutaneous coronary intervention Circulation 114 2006 249 255
30. R.J. Applegate, M.T. Sancrity, W.C. Little, R.M. Santos, S.K. Gandhi, and M.A. Kutcher Incidence of coronary stent thrombosis based on Academic Research Consortium definitions Am J Cardiol 102 2008 683 688
31. A. Kapur, I.S. Malik, J.P. Bagger, J.R. Anderson, J.S. Kooner, and M. Thomas The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design Am Heart J 149 2005 3 19
32. A.T.L. Ong, P.W. Serruys, F.W. Mohr, M.C. Morice, A.P. Kappetein, and D.R. Holmes Jr The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, run-in phase Am Heart J 151 2006 1194 1204
33. Future Revascularization Evaluation in patients with diabetes mellitus: Optimal Management of Multivessel Disease (FREEDOM) [citado 19 May 2008] Disponible en: http://www.clinicaltrials.gov/ct/show/NCT00086450?order=1
34. R.A. Corpus, P.B. George, J.A. House, S.R. Dixon, S.C. Ajluni, and W.H. Devlin Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention J Am Coll Cardiol 43 2004 8 14
35. A. Dibra, A. Kastrati, J. Mehilli, J. Pache, H. Schuhlen, N. Von Beckerath ISAR-DIABETES Study Investigators Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670